Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
ELOX was delisted on the 13th of October, 2023.
38 hedge funds and large institutions have $11.7M invested in Eloxx Pharmaceuticals, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 11 closing their positions.
0.48% more ownership
Funds ownership: 18.69% → 19.16% (+0.48%)
5% less funds holding
Funds holding: 40 → 38 (-2)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
43% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 14
55% less capital invested
Capital invested by funds: $26M → $11.7M (-$14.4M)
75% less call options, than puts
Call options by funds: $15K | Put options by funds: $59K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
+$1.28M |
| 2 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$730K |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$603K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$238K |
| 5 |
VF
Virtu Financial
New York
|
+$142K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$1.82M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$343K |
| 3 |
Vanguard Capital Wealth Advisors
Denver,
Colorado
|
-$304K |
| 4 |
Two Sigma Advisers
New York
|
-$259K |
| 5 |
Two Sigma Investments
New York
|
-$215K |
ELOX Hedge Fund Activity: Q4 2021 in Review
38 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) for Q4 2021, worth a combined $11.7M — down 55% from $26M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of ELOX and 9 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 8 added.
The largest buyer was Harel Insurance Investments & Financial Services, opening a new position worth an estimated $1.28M. The largest seller was Altium Capital Management, exiting entirely with an estimated $1.82M sold.
- 38 institutional investors held Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) as of Q4 2021, down from 40 in Q3 2021.
- Funds reported $11.7M of Eloxx Pharmaceuticals, Inc. Common Stock stock for Q4 2021, down 55% quarter-over-quarter.
- 9 funds opened new Eloxx Pharmaceuticals, Inc. Common Stock positions in Q4 2021 and 11 closed out, a net change of -2 holders.
- The largest Eloxx Pharmaceuticals, Inc. Common Stock buyer in Q4 2021 was Harel Insurance Investments & Financial Services, an estimated $1.28M added.
- The largest Eloxx Pharmaceuticals, Inc. Common Stock seller in Q4 2021 was Altium Capital Management, an estimated $1.82M sold.
Based on aggregated 13F filings for Q4 2021.